
Quali sono i rischi di un trapianto di polmone?
Revisione paritaria di Dr Sarah JarvisAutore Amberley DavisPubblicato originariamente 17 Nov 2021
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Si stima che il 50% delle persone sottoposte a un trapianto di polmone sopravviva almeno cinque anni dopo l'intervento. Un tasso di sopravvivenza a lungo termine di appena metà di tutti i pazienti dimostra che i trapianti di polmone comportano rischi considerevoli. I trapianti di polmone sono quindi generalmente un trattamento di ultima istanza per condizioni fatali.
How many people survive a lung transplant?
In the last year, 91 people have undergone a lung transplant in the UK. Survival of the surgery is around 90%, according to the British Transplantation Society (BTS). Most of these people will survive for at least a year after the operation, and one 2017 study puts this figure at 85%. However, this study also emphasises that this figure has not improved in recent years, despite technological improvements in the field.
Just 50% of people are expected to survive beyond five years after having a lung transplant. Ricerca suggests that the average number of years that transplant recipients live for post-surgery is 6.2 years. Of those who survive the first year, the median of years of survival then becomes 8.3 years. Although rare, there have also been documented cases of people living for over 20 years.
While these odds may seem grim, it is important to remember that those eligible for a transplant typically have no other treatment options and have a life expectancy without treatment of 2-3 years or less.
What is a lung transplant?
Put simply, a lung transplant is a surgery in which a diseased lung is replaced with a healthy lung taken from another person known as a 'donor'. Most lungs are transplanted from deceased organ donors and this type of transplantation is known as a cadaveric transplant. Some lungs are transplanted from living, healthy adults who are a good match with the patient, and this is known as a living transplant.
People of almost all ages can be eligible for lung transplants, from newborns to adults up to 65 years and sometimes older.
What are the types of lung transplant procedures?
There are four types of lung transplant procedures:
Single lung - a transplant of one lung.
Double lung - a transplant of both lungs.
Bilateral sequential/bilateral single - a transplant of both lungs, done one at a time.
Heart-lung - a transplant of both lungs and the heart taken from a single donor.
Who may need a lung transplant?
People who have serious lung problems that can't be improved with other treatments and those whose life expectancy is less than 2-3 years are the usual candidates for lung transplant.
The following conditions can cause serious lung damage and may be treated with a lung transplant:
Fibrosi cistica - an inherited disease that causes the lungs and digestive system to become clogged with mucus.
Malattia polmonare ostruttiva cronica (COPD) - a severe lung condition that obstructs normal breathing.
Displasia broncopolmonare - a lung disease that causes breathing problems from birth.
Malattie cardiache - a disease that can affect the lungs and may require a heart-lung transplant.
Polmonare ipertensione - high blood pressure in the arteries of the lungs.
Fibrosi polmonare - scarring of the lungs.
There are also other diseases that can cause serious lung damage, including certain hereditary conditions. Not everyone who has these conditions needs a lung transplant. It is also not advised to have a lung transplant as a treatment for cancro ai polmoni.
Quali sono i rischi di un trapianto di polmone?
A lung transplant is a complex surgical procedure, and it carries a high risk of complications. That said, it has proven to be an effective treatment for people with severe lung problems. Lung transplants can greatly improve a person's quality of life, reduce symptoms of breathing difficulties and significantly extend their life expectancy.
It is important to discuss both the potential risks and benefits with your healthcare specialist. Your risks may vary depending on your general health and other factors.
The main risks of lung transplants include:
Sanguinamento.
Blockage of the blood vessels to the new lung(s).
Blockage of the airways.
Fluid in the lungs (edema polmonare).
Rejection of the new lung(s).
As a result, a person shouldn't have a lung transplant if they have:
A current or recurring infection that can't be treated.
Cancro that has spread to other parts of the body.
Problemi cardiaci.
Serious health conditions other than lung disease that won't get better after a transplant.
Immune system rejection of a lung transplant
A major risk is that the sistema immunitario will reject the new lung(s). When a foreign organ is transplanted into a body, the immune system sees that object as a threat and attacks it. This is a normal, healthy reaction: as a result, lung transplant recipients need to take immunosuppressant medicines, which reduce the chance of rejecting the organ.
It is important to contact your specialist if you experience any of the following signs of rejection:
A feeling of suffocating or drowning.
A febbre alta of 38°C or more.
A tosse.
Influenzasimili all'influenza.
Stanchezza.
A new toracico.
Studi have shown that lung transplant rejection leads to acute graft failure, and this then causes chronic lung allograft dysfunction (CLAD). The most common form of CLAD, bronchiolitis syndrome (BOS), is the main cause of death in people who have received lung transplants. Half of these people develop BOS within five years of the transportation.
Side effects of anti-rejection medication
Anti-rejection medicines, known as immunosuppressants, carry other potentially serious risks. As well as increasing the chances of infection, they can lead to the development of other serious conditions, including:
High blood pressure (ipertensione).
Other side effects include:
A growth in facial hair.
Stomach problems.
Infection from a lung transplant
Infezione is always a risk during lung transplant surgery, but this risk is increased by taking immunosuppressants. Studi have found infection to be "a significant complication" that represents the "most common cause of death within the first year".
In addition to reducing the chance of rejection, these immunosuppressant medicines also reduce the immune system's ability to fight off bacteria, viruses and fungi. This in turn makes recipients more prone to severe infections. Anyone who has had a lung transplant needs to take steps to avoid infection, and to seek prompt treatment at the first sign of infection. These include:
Burning or stinging on urination, or a need to urinate frequently.
Offensive-smelling urine.
Confusione.
Cuts, sores or wounds that don't heal.
Considering the risks, benefits and management of a lung transplant
The risks will differ from person to person, depending on factors such as age and other existing health conditions.
Your healthcare specialist will talk you through the risks of a lung transplant as well as the potential benefits.
You will also need to consider the long-term management after having a lung transplant. You may need to take immunosuppression medication for the duration of your life. Modulating your natural immune system response is critical in preventing organ rejection.
Scelte del paziente per Chirurgia e procedure

Trattamenti e farmaci
Le esperienze di un chirurgo vasectomizzato
Non ricordo esattamente come sono stato coinvolto nelle vasectomie. Il socio senior uscente le eseguiva nello studio a cui mi sono unito come medico di base e penso che, come nuovo arrivato, mi aspettassero semplicemente di prenderne il comando. Sono stato mandato alla clinica locale di vasectomia per essere formato.
di Dr Laurence Knott

Trattamenti e farmaci
Avere rapporti sessuali dopo una vasectomia
Sebbene ci siano segnalazioni di alcuni uomini che provano dolore a lungo termine nello scroto, la stragrande maggioranza degli uomini che hanno subito una vasectomia non nota alcuna differenza, nemmeno durante il rapporto sessuale.
di Dr Colin Tidy, MRCGP
Informazioni sul recensoreVisualizza il profilo completo

Dr Sarah Jarvis
Consulente Clinico
MA (Cantab), BM, BCh (Oxon), DRCOG, FRCGP, MBE
Dopo aver completato la formazione in medicina a Cambridge e Oxford, la Dott.ssa Sarah Jarvis MBE è diventata un medico di base.
Storia dell'articolo
Articolo disponibile anche in Inglese, Tedesco, Spagnolo, Francese, Italiano, Portoghese, Hindi, Ebraico, Arabo, and Svedese.
17 Nov 2021 | Pubblicato originariamente
Autore:
Amberley DavisRevisione paritaria di
Dr Sarah Jarvis
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.


